Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Perit Dial Int ; 35(2): 128-34, 2015.
Article in English | MEDLINE | ID: mdl-24711639

ABSTRACT

Management of the pregnant patient on peritoneal dialysis (PD) is potentially challenging because uterine enlargement may negatively affect catheter function and prescribed dwell volumes. Additional reports of the management of these patients are needed. Here, we describe a near-full-term delivery in a 27-year-old woman who had been on dialysis for 7 years. Peritoneal dialysis was continued during the entire pregnancy. In the third trimester, a higher delivered automated PD volume allowed for adequate clearance and control of volume status. A decision to hospitalize the patient to limit activity and facilitate the delivery of increased dialysate is believed to have contributed to the successful outcome for mother and infant. Our report discusses the management of this patient and reviews published dialysis prescriptions used during the third trimester of pregnancy in patients treated with PD.


Subject(s)
Kidney Failure, Chronic/therapy , Peritoneal Dialysis , Pregnancy Complications/therapy , Pregnancy Trimester, Third , Adult , Female , Humans , Pregnancy
2.
Am J Perinatol ; 26(5): 373-7, 2009 May.
Article in English | MEDLINE | ID: mdl-19067279

ABSTRACT

Fetal tachycardia caused by the transplacental passage of thyroid stimulating immunoglobulin is well established, but very little information exists regarding the fetal heart rate appearance of this form of tachycardia. Two cases of fetal tachycardia are described in pregnancies complicated by fetal thyrotoxicosis where maternal thyroid history was unknown at the time of testing. For each pregnancy, the fetal heart monitor tracing is depicted and described. In both cases, the initial fetal heart rate pattern demonstrated a sustained baseline of 170 to 180 beats per minute with moderate variability that exhibited accelerations with a lack of decelerations. The tracings were essentially normal except for the baseline rate. When reviewing the differential for fetal tachycardia presenting in the antenatal period, this pattern is unique to fetal thyrotoxicosis, especially if the mother is afebrile and there is no history of medication usage that could explain this presentation.


Subject(s)
Cardiotocography , Heart Rate, Fetal , Pregnancy Complications , Tachycardia/diagnosis , Tachycardia/etiology , Thyrotoxicosis/complications , Adult , Antithyroid Agents/therapeutic use , Female , Follow-Up Studies , Heart Rate, Fetal/drug effects , Humans , Pregnancy , Pregnancy Complications/diagnosis , Pregnancy Complications/drug therapy , Pregnancy Outcome , Propylthiouracil/therapeutic use , Thyrotoxicosis/diagnosis , Thyrotoxicosis/drug therapy , Thyroxine/therapeutic use , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...